This document provides a financial analysis of Cipla Ltd, an Indian pharmaceutical company, including:
- A summary of the company's latest yearly and quarterly results showing declines in EBDITA but growth in adjusted PAT.
- A valuation matrix comparing the company's stock to industry ratios like P/E and P/Book Value.
- An analysis of the company's return on equity over the past 5 years, showing an increase in reported PAT/PBT to 2.31 in March 2011.
- Sections analyzing the company's income statement, balance sheet, cashflow statement, quarterly results, and various financial ratios over time.